Group 1 - The article reports on share buybacks conducted by several companies on August 14, 2025, with Hang Seng Bank having the largest buyback amount of 22.867 million HKD for 200,000 shares [1][2] - The total number of shares repurchased by each company varies, with MGM China repurchasing 1,000,000 shares for 16.1807 million HKD, and FIH Mobile repurchasing 208,000 shares for 3.1104 million HKD [2] - The cumulative buyback amounts for the year show that Hang Seng Bank has repurchased a total of 2 million shares, representing 0.106% of its total share capital [2] Group 2 - The buyback activity indicates a trend among companies to return capital to shareholders, with notable participation from firms like HYPEBEAST and North Forest Holdings, which repurchased 935,200 and 9,600 shares respectively [2] - The buyback amounts and percentages of total share capital for other companies include FIH Mobile at 0.401%, and Yanzheng Technology at 1.082%, indicating varying levels of commitment to share repurchase programs [2] - The data reflects a broader strategy among these companies to enhance shareholder value through share buybacks, which can signal confidence in their financial health [1][2]

Group 1: Core Insights - Rongchang Biologics (09995.HK) announced that its innovative drug Taitasip (brand name: Tai Ai®) for treating primary Sjögren's syndrome has met the primary endpoint in a Phase III clinical trial in China [1] - Taitasip is the first BLyS/APRIL dual-target fusion protein drug to complete Phase III research in the field of Sjögren's syndrome globally [1] - The clinical trial was a multi-center, randomized, double-blind, placebo-controlled study aimed at evaluating the efficacy and safety of Taitasip, with the primary endpoint being the change in ESSDAI score at week 24 compared to baseline [1] Group 2: Disease Background and Drug Mechanism - Sjögren's syndrome is a chronic inflammatory autoimmune disease characterized by lymphocytic infiltration and damage to exocrine glands, leading to persistent dry mouth and dry eyes, and can affect multiple organ systems [2] - The prevalence of Sjögren's syndrome in China is estimated to be between 0.3% and 0.7%, with an increasing trend indicating a significant unmet clinical need [2] - Taitasip is a novel dual-target fusion protein developed by the company that simultaneously inhibits the overexpression of BLyS and APRIL, effectively preventing abnormal differentiation and maturation of B cells [2] Group 3: Regulatory and Clinical Recognition - Taitasip has received multiple authoritative guideline recommendations in China, including the "Clinical Practice Guidelines for Sjögren's Syndrome" and the "Expert Consensus on B-cell Targeted Therapy for Rheumatic and Immune Diseases" [2] - Internationally, Taitasip has been granted Fast Track designation by the U.S. FDA for its indication in Sjögren's syndrome and has been approved to conduct global multi-center Phase III clinical trials [2]

Core Viewpoint - Hang Seng Bank has been actively repurchasing its shares, indicating a strategy to support its stock price and enhance shareholder value [2] Summary by Category Share Buyback Activity - On August 14, Hang Seng Bank repurchased 200,000 shares at a price range of HKD 113.600 to HKD 115.400, totaling HKD 22.867 million [2] - Since August 1, the bank has conducted share buybacks for 10 consecutive days, acquiring a total of 2 million shares for a cumulative amount of HKD 228 million [2] - During this period, the stock price has increased by 0.34% despite the recent buyback activities [2] Stock Performance - The closing price of Hang Seng Bank on August 14 was HKD 113.700, reflecting a decrease of 0.87% for the day [2] - The total trading volume for the day was HKD 287 million [2] Detailed Buyback Data - The following table summarizes the buyback details for the past days: | Date | Shares Repurchased (thousand) | Highest Price (HKD) | Lowest Price (HKD) | Buyback Amount (thousand HKD) | |------------|-------------------------------|---------------------|--------------------|-------------------------------| | 2025.08.14 | 20.00 | 115.400 | 113.600 | 2286.70 | | 2025.08.13 | 20.00 | 115.800 | 114.400 | 2296.14 | | 2025.08.12 | 20.00 | 115.400 | 114.100 | 2300.02 | | 2025.08.11 | 20.00 | 116.200 | 115.100 | 2315.60 | | 2025.08.08 | 20.00 | 114.700 | 113.800 | 2286.94 | | 2025.08.07 | 20.00 | 115.100 | 113.200 | 2289.15 | | 2025.08.06 | 20.00 | 113.600 | 112.800 | 2263.47 | | 2025.08.05 | 20.00 | 114.200 | 113.100 | 2271.70 | | 2025.08.04 | 20.00 | 114.000 | 111.900 | 2267.19 | | 2025.08.01 | 20.00 | 114.300 | 112.400 | 2259.22 | [2]

恒生银行(00011)发布公告，于2025年8月14日，该公司斥资2286.7万港元回购20万股。 ...

智通财经APP讯，恒生银行(00011)发布公告，于2025年8月14日，该公司斥资2286.7万港元回购20万 股。 ...

Group 1 - Hang Seng Bank announced a share buyback plan on August 14, 2025, involving an expenditure of HKD 22.867 million to repurchase 200,000 shares [1] - The buyback price range is set between HKD 113.6 and HKD 115.4 per share [1]

| 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | | 00011 | 說明 | 股份 | | | | | | | 多櫃檯證券代號 | | 80011 | RMB 說明 | 股份 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | | 於下列日期開始時的結存(註1) | | 2025年8月13日 | | 1,882,267,536 | | 0 | | | 1,882,267,536 | | 1). 其 ...

大摩认为，中银香港(02388)股息回报将获支持，相信即将公布的中期业绩当中净息差将受压，但非利 息收入预料表现强劲，将关注管理层对信贷质素及资本管理的看法，予"减持"评级，目标价从24.7港元 上调至31.4港元。该行又指，恒生银行(00011)估值偏高，维持减持评级，目标价由93港元升至94.5港 元。 智通财经APP获悉，摩根士丹利发布研报称，上半年本地利率因素及信贷质素风险持续，一众银行股中 较偏好国际银行多于本地银行，因本地银行估值偏高，而国际性银行估值相对合理、资本回报具支持及 前景正面，维持对汇丰控股(00005)及渣打集团(02888)的"增持"评级。 （原标题：大摩：港银中偏好估值合理的国际性银行 予汇丰控股(00005)及渣打集团(02888)"增持"评 级） 该行认为，银行股第二季业绩将主要受HIBOR下跌及香港商业地产信贷质素恶化的影响，预料财富管 理业务及市场收入可抵销部分压力，但相信下半年挑战仍存在，预计银行净利息收入及净息差将于第三 季录得按季下跌，至第四季有望轻微复苏。随着美国利率预期下降，大摩预期2026年净息差可进一步收 窄。 ...

Group 1 - On August 13, seven Hong Kong-listed companies conducted share buybacks, totaling 1.8705 million shares and an amount of 45.2591 million HKD [1][2] - The company with the highest buyback amount on August 13 was Hang Seng Bank, which repurchased 200,000 shares for 22.9614 million HKD, with a year-to-date total buyback amount of 205.49 million HKD [1][2] - MGM China repurchased 1 million shares for 15.9846 million HKD, with a year-to-date total buyback amount of 86.6466 million HKD [1][2] Group 2 - The buyback prices for Hang Seng Bank ranged from a maximum of 115.800 HKD to a minimum of 114.400 HKD [1][2] - For MGM China, the buyback prices ranged from a maximum of 16.070 HKD to a minimum of 15.870 HKD [1][2] - FIH Mobile Limited (富智康集团) repurchased 211,000 shares for 3.1187 million HKD, with a year-to-date total buyback amount of 34.4219 million HKD [1][2]

Group 1 - The companies that conducted share buybacks on August 13, 2025, include Hang Seng Bank, MGM China, FIH Mobile, Yuan Zheng Technology, North Forest Holdings, and International Home Retail [1] - Hang Seng Bank had the largest buyback amount, repurchasing 200,000 shares for a total of 22.96 million [1] - The total number of shares repurchased by Hang Seng Bank in the year reached 1.8 million, accounting for 0.096% of its total share capital [2] Group 2 - MGM China repurchased 1 million shares for a total of 15.98 million, with a year-to-date total of 5.63 million shares, representing 0.148% of its total share capital [2] - FIH Mobile repurchased 211,000 shares for a total of 3.12 million, with a year-to-date total of 2.95 million shares, representing 0.374% of its total share capital [2] - North Forest Holdings repurchased 20,000 shares for a total of 1.66 million, with a year-to-date total of 6.19 million shares, representing 0.881% of its total share capital [2] - Yuan Zheng Technology repurchased 107,500 shares for a total of 1.40 million, with a year-to-date total of 1.70 million shares, representing 1.054% of its total share capital [2] - International Home Retail repurchased 150,000 shares for a total of 0.13 million, with a year-to-date total of 3.57 million shares, representing 0.493% of its total share capital [2] - Meiheng Industrial repurchased 2,000 shares for a total of 0.90 million, with a year-to-date total of 3.57 million shares, representing 0.870% of its total share capital [2]